Synthesis of the tripeptide (C1-N12) and hydroxylated hexadecene (C26-C41) domains of sanglifehrin A and C

Tetrahedron Letters

Volumn 40, Issue 42, 1999, Pages 7441-7444

  Paquette, Leo A ^a   Konetzki, Ingo ^a   Duan, Maosheng ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aldols; Aminal; Immunosuppressive compounds; Peptide; Stereocontrol

Indexed keywords

ALDEHYDE; AMINO ACID DERIVATIVE; HEXADECENE; IMMUNOSUPPRESSIVE AGENT; SANGLIFEHRIN A; SANGLIFEHRIN C; TRIPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; ENANTIOMER; PARTIAL DRUG SYNTHESIS; STEREOCHEMISTRY;

EID: 0033570293     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)01539-7     Document Type: Article

References (21)

1. (a) Fehr, T.; Oberer, L. Intern. Patent Appl. W097/02285 (January 23, 1997). (b) Fehr, T.; Oberer, L.; Quesniaux, R. V.; Sanglier, J.-J.; Schuler, W.; Sedrani, R. Intern. Patent Appl. W098/07743 (March 3, 1998).
2. (a) Fehr, T.; Oberer, L. Intern. Patent Appl. W097/02285 (January 23, 1997). (b) Fehr, T.; Oberer, L.; Quesniaux, R. V.; Sanglier, J.-J.; Schuler, W.; Sedrani, R. Intern. Patent Appl. W098/07743 (March 3, 1998).
3. The affinity of 1 for cyclophilin A is 20-fold greater than that exhibited by cyclosporin A.
4. Bänteli, R.; Brun, I.; Hall, P.; Metternich, R. Tetrahedron Lett. 1999, 40, 2109.
5. Nicolaou, K. C.; Ohshima, T.; Murphy, F.; Barluenga, S.; Xu, J.; Winssinger, N. Chem. Commun. 1999, 809.
6. The enantiomer of 3 has been previously reported: Hale, K. J.; Delisser, V. M.; Manaviazar, S. Tetrahedron Lett. 1992, 33, 7613.
7. Bender, D. M.; Williams, R. M. J. Org. Chem. 1997, 62, 6690.
8. Lapatsanis, L.; Milias, G.; Froussios, K.; Kolovos, M. Synthesis 1983, 671.
9. Dourtoglu, V.; Ziegler, J.-C.; Gross, B. Tetrahedron Lett. 1978, 1269.
10. Evans, D. A.; Ennis, M. D.; Le, T.; Mandel, N.; Mandel, G. J. Am. Chem. Soc. 1984, 106, 1154.
11. Chakraborty, T. K.; Suresh, V. R. Tetrahedron Lett. 1998, 39, 7775.
12. The formation of an inseparable by-product (N-pivaloyloxazolidinone) was observed if the same reaction was carried out under the conditions described by Evans (Evans, D. A.; Gage, J. R.; Leighton, J. L. J. Am. Chem. Soc. 1992, 114, 9434).
13. (a) Paterson, I.; Tillyer, R. D. Tetrahedron Lett. 1992, 33, 4233. (b) Paterson, I.; Norcross, R. D.; Ward, R. A.; Romea, P.; Lister, M. A. J. Am. Chem. Soc. 1994, 116, 11287.
14. (a) Paterson, I.; Tillyer, R. D. Tetrahedron Lett. 1992, 33, 4233. (b) Paterson, I.; Norcross, R. D.; Ward, R. A.; Romea, P.; Lister, M. A. J. Am. Chem. Soc. 1994, 116, 11287.
15. Murata, M.; Matsuoka, S.; Matsumori, N.; Paul, G. K.; Tachibana, K. J. Am. Chem. Soc. 1999, 121, 870.
16. Evans, D. A.; Chapman, K. T.; Carreira, E. M. J. Am. Chem. Soc. 1988, 110, 3560.
17. The previously unknown ketone 17 was prepared by acylation of (S)-4-benzyl-2-oxazolidinone with 5-hexenoic acid, enantiocontrolled α-methylation of the amide, formation of the Weinreb amide, and condensation of the latter with methyllithium.
18. Paterson, I.; Cumming, J. G.; Smith, J. D.; Ward, R. A. Tetrahedron Lett. 1994, 35, 441.
19. Evans, D. A.; Carter, P. H.; Carreira, E. M.; Prunet, J. A.; Charette, A. B.; Lautens, M. Angew. Chem., Int. Ed. Engl. 1998, 37, 2354.
20. Franklin, A. S.; Paterson, I. Contemporary Organic Synthesis 1994, 9477.
21. Claus, E.; Kalesse, M. Tetrahedron Lett. 1999, 40, 4157.